GroupImage
MONTLICK & ASSOCIATES, Attorneys at Law
17 Executive Park Drive
Atlanta, GA 30329
1-800-LAW-NEED


Back-over accidents generating product liability litigation


Parents while backing up their vehicles are increasingly running over their children, in large part due to the popularity of SUVs and other larger vehicles with large rear “blind zones,” according to the vehicle safety advocacy group Kids & Cars.

The organization estimates that on average at least 50 children a week are hit by backing up vehicles, resulting in two deaths and 48 trips to emergency rooms.

These incidents may be happening because SUVs aren’t equipped with technology that can show or tell drivers what’s behind them. Although some models do feature beeping rear-end sensors, rear-view cameras and dashboard monitors, many do not.

The result is that some of these back-over incidents are generating lawsuits claiming the vehicles are defective for

 

their lack of safety features. Thus far, only two cases have gone to trial and both resulted in losses for those who filed the lawsuits against the auto manufacturers. But that’s not uncommon when new topics are heard in court.

The lawsuits involving back-over injuries are expected to increase.

Manufacturers are claiming that if a parent doesn’t look before backing up, no safety precautions in the world will protect a child. They’ll also say it’s the responsibility of adults to know where children are at all times, especially near vehicles.

Consumer attorneys will likely argue in response that this is a design defect of the vehicle, not merely an accident. Also, because new safety technology exists, there’s no justification for not using it.


Line


Deep vein thrombosis claims against airlines allowed


Airline passengers can sue international airlines for injuries caused by deep vein thrombosis, but only if the circumstances of their injuries match a specific pattern, a California court recently ruled.

An airline, for example, would need to refuse to reseat a passenger, fail to respond to a passenger’s medical emergency, or the plane would need to be delayed before takeoff.

The airlines argued deep-vein thrombosis is not an “accident,” but the court ruled that circumstances can arise during travel that could create an accident.

One passenger was hospitalized and

 

had to have surgery because of the injuries she suffered when an airline refused to reseat her in a less-cramped seat after she complained of leg pain. Another developed the condition several days after his flight, which had been delayed for a long time prior to take off. Passengers on that flight were instructed to remain seated with their seatbelts on for more than two hours.

Yet another passenger passed out in the aisle from a deep-vein thrombosis-related injury and died. The airline did not treat her for the condition when she landed, despite another passengers’ discovering a blood clot behind her knee.


Line


Pharmacist can be sued for breaching an implied warranty


A pharmacist who improperly mixed a prescription intravenous nutrient solution can be sued for breaching an implied warranty, according to a recent court ruling.

In the case, the pharmacist’s customer had much of her small intestine removed and had to get nourishment from an intravenous water-based solution the pharmacist mixed for her.

After injecting the solution from a bag mixed by the pharmacist’s technician, the customer suffered chills, vomiting and diarrhea. She was hospitalized and so

 

weakened by her condition that she eventually died.

Experts testified at trial that the intravenous bags were contaminated.

The Florida Court of Appeal said the woman’s estate could pursue an implied warranty claim because the pharmacist was not merely reselling and dispensing a drug received from a drug manufacturer.

Where the pharmacist is actually mixing the drug in question and in that process allegedly contaminates the mixture, a warranty claim exists, the court said.


Line


Vioxx settlement reached


The manufacturer of the painkiller Vioxx has settled the majority of claims for injuries linked to the drug.

Merck & Co. will pay $4.85 billion to resolve most of the claims that had been filed by Nov. 9, 2007. The company will set up a $4 billion fund for claims of myocardial infarction and an $850 million fund for ischemic stroke claims. The amount awarded to individual plaintiffs will vary, but is estimated at about $100,000 before legal fees and expenses.

Merck faced more than 27,000 lawsuits from people who claim to have been injured by the widely used arthritis and pain medicine.

Those seeking settlement funds will have to prove they had a heart attack or stroke and had been on Vioxx at least 14 days prior to the injury. Each claim will be evaluated separately, based on age, level of injury, how long a person was taking Vioxx and their personal risk factors.

In these cases, it can be very difficult to prove a heart attack or stroke was caused by the drug because there are so many causes of those health problems.

 

More than 20 million Americans took Vioxx before Merck pulled it off the market in September 2004 after a long-term study showed it could double the risk of heart attack or stroke if taken for 18 months or longer.


Line


The fight over class action arbitration bans continues


Consumer rights lawyers are challenging corporate efforts to bar the use of arbitration to handle class actions.

A 2003 U.S. Supreme Court ruling opened the doors to arbitrating class actions. Arbitration is a proceeding to resolve legal disputes, and is usually less formal and quicker than handling a case in court. Decisions by arbitrators are usually binding.

Since the Supreme Court ruling, banks, credit companies and employers have been adding waivers to arbitration contracts specifically exempting class actions from arbitration. Consumer lawyers have responded by challenging the waivers in state and federal courts.

Historically, consumer rights lawyers have usually opposed clauses in consumer and employment contracts that mandate arbitration to resolve disputes, claiming that consumers don’t always get a fair hearing in arbitration and that they should have the choice of filing a lawsuit or going to arbitration.

But if the choice is between no class actions and class action arbitration, then arbitration is an acceptable alternative to consumers.

Arbitration can work well to resolve

 

disputes if an arbitrator or panel of arbitrators can devote more consistent attention and more hours to a class action than a court.

Over the past four years, federal and state courts have issued more than 50 rulings on class action arbitration waivers, but the rulings have been inconsistent. Consumer lawyers have successfully challenged class action bans in several states, including Alabama, California, Illinois, New Jersey, Washington, West Virginia, Florida, Missouri, Ohio, Oregon, Pennsylvania, and Wisconsin. Federal courts in Arizona, California, Florida, Massachusetts, Michigan, Missouri, and Washington have also upheld challenges.

However, state courts in Colorado, Delaware, Georgia, Hawaii, Louisiana, Maine, Maryland, Michigan, Mississippi, New Mexico, New York, North Carolina, North Dakota, Oklahoma, Oregon, Rhode Island, Tennessee, Texas, Utah and the District of Columbia have upheld class arbitration prohibitions.

Either Congress or the U.S. Supreme Court will likely have to step in to determine the legality of class action arbitration bans.


Line


Fibromyalgia testimony allowed


In a victory for fibromyalgia sufferers, a woman in Florida was able to sue the other drivers in four automobile accidents in which she was involved, claiming the trauma of the accidents caused her to develop the condition.

Fibromyalgia is a syndrome involving widespread pain, decreased pain threshold, and a variety of other symptoms. The medical community debates whether it’s real medical condition.

 

Her case ended up in front of the Florida Supreme Court because the drivers claimed she could not sue over the condition because it is not generally recognized in the medical community.

The judges made it clear in their decision that the medical community need not agree unanimously on the particulars of a condition for the woman to make the claim.


Line


Ford settles rollover suits


Ford Motor Co. has settled a lawsuit brought by a group of sport utility vehicle owners who argued the company marketed the Ford Explorer as safe when it knew they had a tendency to rollover.

The lawsuit was filed by owners of the Ford Explorer for model years 1991 through 2001. They were seeking to recover the lost value of their SUVs after it became clear there was a danger the vehicle might rollover.

Anyone who owned an Explorer during the time period is eligible to receive the settlement offer, even if the vehicle was sold or purchased privately and they no longer own it. They will receive

 

certificates for $300 or $500 toward the purchase of another Ford, Lincoln or Mercury vehicle.

The settlement will have no impact on individual cases filed by people who were injured or killed in vehicle rollovers.


Line


Smokers can sue over marketing of ‘light’ cigarettes


Smokers can sue a tobacco company in state court for fraud and misrepresentation in the way it marketed “light” cigarettes. The claims are not preempted by federal law on the labeling of tobacco products, according to a recent court ruling in Minnesota.

The court’s ruling broadens the kind of potential claims available to smokers of light cigarettes.

In the case before the Minnesota Court of Appeals, long-time smokers of Camel Lights and Winston Lights filed a class action against R.J. Reynolds Tobacco Co. They alleged the company violated state consumer protection and unfair trade practice laws. The smokers claimed the tobacco company misrepresented the amount of tar and nicotine they would be exposed to by smoking light cigarettes.

R.J. Reynolds defended its actions, arguing that it only had to comply with the federal law requiring it to say on the packaging labels of its cigarettes that smoking may be hazardous to your health.

 

But the Minnesota Court of Appeals disagreed.

The court said that the claims of fraud and misrepresentation were not directly related to the federal laws on smoking and health. Rather, they were based on a state law prohibiting deceptive behavior towards consumers. As such, the claims could proceed in state court.

The majority of courts around the country that have considered this issue have ruled consistently with the Minnesota ruling, although some courts have decided just the opposite.



This newsletter is designed to keep you up-to-date with changes in the law. For help with these or any other legal issues, please call our firm today.

The information in this newsletter is intended solely for your information. It does not constitute legal advice, and it should not be relied on without a discussion of your specific situation with an attorney.

67.140.194.152/5.93